ICER president Steven Pearson at JPM23 (Adrien Villez for Endpoints News)

At $2M per shot, ICER says two new sick­le cell gene ther­a­pies could be cost-ef­fec­tive

Gene ther­a­pies ap­proved by the FDA have so far brought with them eye-pop­ping prices of $2 mil­lion or more be­cause of the ex­tra­or­di­nary sav­ings, some­times …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.